Single and multiple point NRAS mutations in acute myeloid leukemia: a study of 327 well molecularly characterized patients

Authors:

Abstract
Oncogenic mutations in the NRAS gene are carried by 10–22% acute myeloid leukemia (AML) patients and represent one of the most commonly detected molecular aberrations in AML [1–6]. The mutations le...
Funding Information
  • Ministry of Health of the Czech Republic (15-25809A)
  • Ministry of Education, Youth and Sports of the Czech Republic (MUNI/A/1330/2021)
  • Ministry of Health of the Czech Republic (FNBr, 65269705)